Corpus Intelligence IC Memo — SUTTER MATERNITY & SURGERY CENTER 2026-04-26 14:13 UTC
IC Memo — SUTTER MATERNITY & SURGERY CENTER
Investment Committee Memorandum | CA | 28 beds | Grade C | EBITDA uplift $6.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SUTTER MATERNITY & SURGERY CENTER

CCN 050714 | SANTA CRUZ, CA | 28 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SUTTER MATERNITY & SURGERY CENTER is a 28-bed suburban community hospital in SANTA CRUZ, CA with $90.5M in net patient revenue and a 12.8% operating margin. The hospital serves a payer mix of 4.6% Medicare, 15.3% Medicaid, and 80.1% commercial.

Thesis: Turnaround. Our ML models identify $6.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 12.8% to 20.1% (+736bps).

Net Revenue HCRIS$90.5M
Current EBITDA COMPUTED$11.6M
Operating Margin COMPUTED12.8%
Occupancy HCRIS37.5%
Revenue / Bed COMPUTED$3.2M
Net-to-Gross HCRIS35.9%
Distress Probability ML50.2%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
72
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of 12.8% places it above the state median. Among 72 size-comparable peers (14-56 beds), the median margin is -6.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (14-56), prioritizing same-state peers. 72 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SUTTER MATERNITY & SURGERY CEN (Target)CA28$90.5M12.8%
TAHOE FOREST HOSPITALCA25$264.3M13.0%
PORTERVILLE DEVELOPMENTAL CENTCA17$193.6M-6.0%
ADVENTIST HEALTH REEDLEYCA49$187.1M1.8%
SUTTER DAVIS HOSPITALCA48$176.9M12.5%
ADVENTIST HEALTH UKIAH VALLEYCA50$173.4M-39.9%
ADVENTIST HEALTH CLEARLAKECA25$159.9M-6.3%
ST ELIZABETH COMMUNITY HOSPTICA49$159.2M3.5%
RIDGECREST REGIONAL HOSPITALCA25$149.6M-14.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.9M+210bp18mo
Cost to Collect4.5%2.5%$1.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.1M+122bp9mo
Clean Claim Rate88.0%96.0%$58K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.9M
Cost to Collect
$1.8M
Denial Rate Reduction
$1.8M
A/R Days Reduction
$1.1M
Clean Claim Rate
$58K
Total EBITDA Uplift$6.7M
Current EBITDA$11.6M
+ RCM Uplift+$6.7M
Pro Forma EBITDA$18.2M
Current Margin12.8%
Pro Forma Margin20.1%
WC Released (1x)$3.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$17.8M$143.0M8.03x51.7%
Base (11x exit)10.0x11.0x$17.8M$163.1M9.16x55.7%
Bull Case9.0x11.0x$16.0M$190.9M11.91x64.1%
Bull (12x exit)9.0x12.0x$16.0M$213.0M13.29x67.8%
Bear Case11.0x10.0x$19.6M$103.9M5.30x39.6%
Bear (11x exit)11.0x11.0x$19.6M$120.7M6.16x43.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 50.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 72 hospitals with 14-56 beds
  • Same-state prioritization (n=73)
  • Comp margins: P25=-17.6% / P50=-6.3% / P75=1.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.